1 BACKGROUND: Heart failure (HF) is characterized by electrophysiological remodeling resulting in increased risk of cardiac arrhythmias. Previous reports suggest that elevated inward ionic currents in HF promote action potential (AP) prolongation, increased short-term variability of AP repolarization, and delayed afterdepolarizations. However, the underlying changes in late Na + current (I NaL ), L-type Ca 2+ current, and NCX (Na + /Ca 2+ exchanger) current are often measured in nonphysiological conditions (square-pulse voltage clamp, slow pacing rates, exogenous Ca 2+ buffers).
METHODS:
We measured the major inward currents and their Ca 2+ -and β-adrenergic dependence under physiological AP clamp in rabbit ventricular myocytes in chronic pressure/volume overload-induced HF (versus age-matched control).
RESULTS:
AP duration and short-term variability of AP repolarization were increased in HF, and importantly, inhibition of I NaL decreased both parameters to the control level. I NaL was slightly increased in HF versus control even when intracellular Ca 2+ was strongly buffered. But under physiological AP clamp with normal Ca 2+ cycling, I NaL was markedly upregulated in HF versus control (dependent largely on CaMKII [Ca 2+ / calmodulin-dependent protein kinase II] activity). β-Adrenergic stimulation (often elevated in HF) further enhanced I NaL . L-type Ca 2+ current was decreased in HF when Ca 2+ was buffered, but CaMKII-mediated Ca 2+ -dependent facilitation upregulated physiological L-type Ca 2+ current to the control level. Furthermore, L-type Ca 2+ current response to β-adrenergic stimulation was significantly attenuated in HF. Inward NCX current was upregulated at phase 3 of AP in HF when assessed by combining experimental data and computational modeling.
CONCLUSIONS:
Our results suggest that CaMKII-dependent upregulation of I NaL in HF significantly contributes to AP prolongation and increased short-term variability of AP repolarization, which may lead to increased arrhythmia propensity, and is further exacerbated by adrenergic stress.
VISUAL OVERVIEW:
A visual overview is available for this article.
H
eart failure (HF) is characterized by increased risk for cardiac arrhythmias. Arrhythmogenic alterations in the ventricular action potential (AP), including early and delayed afterdepolarizations, [1] [2] [3] [4] AP duration (APD) prolongation, 5, 6 and increased beat-tobeat variability of APD, [6] [7] [8] have been extensively studied in failing ventricular cardiomyocytes. Alterations in membrane potential stability have been associated with extensive ionic remodeling, including enhanced NCX (Na + /Ca 2+ exchanger) current (I NCX ), 9, 10 increased late Na + current (I NaL ), 11, 12 and reduced repolarization reserve. 13, 14 In line with the electrophysiology results, the protein expression level of NCX was also found to be increased in HF, 9 whereas that of several K + channels was decreased. 15 But in the case of Na + channels, both the protein level and peak current density were decreased, 12, 16 suggesting that the increased I NaL in HF results from altered regulation and gating. Accordingly, CaMKII (Ca 2+ /calmodulin-dependent protein kinase II) was found to be centrally involved in I NaL upregulation in HF. [17] [18] [19] However, I NaL in previous HF studies was typically measured in nonphysiological conditions (square-pulse voltage clamp, slow stimulation rates, strong buffering of intracellular Ca 2+ concentration ( [Ca 2+ ] i ), and room temperature), which might have masked some important aspects of I NaL regulation. Indeed, I NaL was found to be larger in AP-clamped healthy guinea pig and rabbit myocytes than the tiny I NaL found in conventional voltage-clamp studies. 20, 21 βAR (β-adrenergic receptor) stimulation can further enhance I NaL (via both CaMKIIdependent and independent mechanisms 19, 21, 22 ), and increased sympathetic activity is commonly observed in HF. Consequently, enhanced I NaL in HF may play a critical role in APD prolongation leading to cardiac arrhythmias and Na + overload. 23 Accordingly, inhibition of either I NaL or CaMKII was found to exert beneficial effects in HF. 18, 24 Unlike upregulated I NCX and I NaL , L-type Ca 2+ current (I CaL ) was found to be unchanged or slightly decreased in previous studies in HF. 4, 25, 26 However, because βAR signaling, Ca 2+ , and CaMKII all regulate I CaL , [27] [28] [29] prior voltage-clamp studies could easily misestimate changes in physiological I CaL or I NaL that occur during the AP in HF.
The present study measures APD, I NaL , I CaL , and I NCX in HF versus control rabbit hearts during physiological APs, with or without βAR activation, and also assesses the involvement of CaMKII. We performed AP-clamp recordings with physiological ionic composition, pacing rate, [Ca 2+ ] i , and temperature. We hypothesized that Ca 2+ transients and increased CaMKII activity under these conditions significantly enhance inward currents in HF leading to arrhythmogenic alterations in AP morphology. We used a previously well-characterized chronic nonischemic HF rabbit model (combined volume and pressure overload), which is also arrhythmogenic. 4, 9, 14, 30 APs and major inward ionic currents were measured under current and AP clamp, respectively, in ventricular myocytes using specific blockers of I NaL (GS-967) and I CaL (nifedipine). Because under physiological conditions, our nifedipine-sensitive current (I Nife ) includes both I CaL and some inward I NCX (because nifedipine inhibits Ca 2+ transients that modulate I NCX ), we included computational modeling to better clarify the distinct profiles of I CaL and I NCX under AP clamp. Modulation of I CaL and I NaL by Ca 2+ , CaMKII, and βAR stimulation (ie, pathophysiological settings characteristic of HF) was also investigated to assess the regulatory changes in the net depolarizing drive during the plateau and repolarization phases of the AP.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request. All animal handling and laboratory procedures were in accordance with the approved protocols of the local Institutional Animal Care and Use Committee confirming to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (eighth edition, 2011).
Arrhythmogenic Rabbit Nonischemic HF Model
HF was induced in New Zealand white rabbits (all male, 2.5-3 kg, and 3-4 months old) by aortic insufficiency and 4 weeks later by aortic constriction as described previously. 9 Data here were obtained from 12 HF rabbits and 8 agematched control rabbits. HF progression was monitored periodically by echocardiography, and myocytes were isolated when left ventricular end-systolic dimension exceeded 1.4 cm (at ≈2.5 years of age). HF animals versus control hearts were near twice the heart weight/body weight (5.27±0.61 versus 2.67±0.10 g/kg; P<0.01), exhibited ≈40% larger
WHAT IS KNOWN?
• Significant ion channel remodeling occurs in heart failure (HF), which results in prolongation of the cardiac action potential (and QT interval in ECG) and increases the risk of arrhythmias.
• Enhanced late Na + current and upregulation of NCX (Na + /Ca 2+ exchanger) have been reported in HF.
WHAT THE STUDY ADDS?
• CaMKII (Ca 2+ /calmodulin-dependent protein kinase II)-dependent and β-adrenergic upregulation of late Na + current in HF enhances the net depolarization drive and significantly contributes to arrhythmogenic action potential alterations in HF.
• 20, 31, 32 Electrodes were connected to the input of an Axopatch 200B amplifier (Axon Instruments), with outputs digitized at 50 kHz using Digidata 1440A A/D card (Molecular Devices) under software control (pClamp 10). Series resistance (on cell) was typically 3 to 5 MΩ and was compensated by 85%. Experiments were discarded when the series resistance was high or increased substantially (>10%) during experiments. Reported AP voltages are already corrected to the liquid junction potentials. All experiments were conducted at 37±0.1 C.
APs were recorded in current-clamp experiments where cells were stimulated with depolarizing pulses (1.5× the threshold amplitude, 2 ms duration) delivered via patch pipette at pacing frequencies from 1 to 5 Hz. After reaching steady state (3 minutes at each frequency), 50 consecutive APs were recorded to measure average behavior. Then pacing was returned to 1 Hz, and the selective I NaL inhibitor GS-967 (1 µmol/L) was added to perfusate. When GS-967 effects stabilized (typically within 3 minutes), AP recordings at different pacing frequencies were repeated. APD at 95% of repolarization (APD 95 ) was determined. Series of 50 consecutive APs were analyzed to estimate short-term variability of APD 95 (STV) according to the following formula: STV=Σ(│AP D n+1 −APD n │)/[(n beats −1)×√2], where APD n and APD n+1 indicate the durations of the n th and (n+1) th APs, and n beats denotes the total number of consecutive beats analyzed. 33 Changes in STV are presented as Poincaré plots of 50 consecutive APD 95 .
AP-clamp experiments were conducted as described previously. 14, 34, 35 Briefly, the basic steps are as follows: (1) record the cell's steady-state AP under I-clamp (self AP clamp) or choose a previously recorded typical AP (canonical AP clamp). (2) Apply this AP onto the cell as voltage command under V-clamp at a given pacing frequency. The net current output (reference current) should reach steady state and be stable over time. (3) Isolate the current of interest by using its specific blocker to remove it from the net current output (compensation current). (4) The current of interest is obtained by subtraction: drug-sensitive current=reference current−compensation current. (5) Next, isolate the second current of interest by applying the second channel blocker; when it reaches steady state, another compensation current is recorded, and the second current of interest can be determined again by subtraction. Figure I in the Data Supplement shows a representative example. Under AP clamp, all ionic currents were recorded as difference currents after each specific blocker had reached its steady-state effect (≈3 minutes of perfusion). Sixty consecutive traces were recorded (to evaluate the stability) and averaged in each case before applying a drug (reference current) and 3 minutes after drug application (compensation current). GS-967 of 1 µmol/L and nifedipine of 10 µmol/L were used to measure I NaL and I CaL (including some I NCX ), respectively. As validated previously, 21 the GS-967-sensitive current recorded in our conditions is an excellent selective measure of I NaL . Experiments were performed both when Ca 2+ cycling was preserved (Physiol) and when [Ca 2+ ] i was buffered below the diastolic level using 10 mmol/L BAPTA [1,2-bis(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid] in the internal solution (BAPTA i ) to assess [Ca 2+ ] i sensitivity of these currents under AP clamp. To test the effect of CaMKII, cells were pretreated for 2 hours before experiment with the specific CaMKII inhibitor, AIP (autocamtide-2-related inhibitory peptide; cell-permeable myristoylated form, 1 µmol/L). Both the perfusion and pipette solutions were also supplemented with AIP. In experiments examining the effect of βAR stimulation, isoproterenol (ISO; 3-300 nmol/L) was applied on AP-clamped cells. After ISO reached a steady-state effect (≈2 minutes), blockers were added sequentially to the perfusion solution to measure I NaL and I CaL Chemicals and reagents were purchased from SigmaAldrich, if not specified otherwise. E-4031 and HMR-1556 were from Tocris Bioscience. GS-967 was from Gilead.
Computational Modeling and Simulation
In silico experiments were performed using our recently updated rabbit ventricular myocyte model 36 that integrates detailed descriptions of membrane electrophysiology, Ca 2+ and Na + handling, 37 PKA (protein kinase A) and CaMKII signaling pathways, 38 and myofilament contraction. 39 This model describes changes in CaMKII activity during each heartbeat, resulting in dynamic functional modulation of CaMKII phosphorylation targets (L-type Ca 2+ channels, ryanodine receptors, and phospholamban). These effects are enhanced in HF, where CaMKII expression and activation is increased (and as in prior work, we elevated CaMKII content to 6-fold). 38 We updated our model to account for HF-induced remodeling, based on our new data here and our previous HF model (including 2-fold increase in NCX maximal transport rate and altered sarcoplasmic reticulum [SR] Ca 2+ release and reuptake). 40 Based on our novel I CaL observations here, we shifted steady-state activation (5 mV negative) but left steady-state inactivation unchanged in HF. We also reduced I CaL maximal conductance (G CaL ) by 20% in HF, resulting in the unaltered peak I CaL that we observed in control versus HF myocytes ( Table I in 
Statistical Analysis
Data are presented as mean±SEM. The number of cells in each experimental group was reported as n=number of cells/number of animals. Statistical significance of differences was tested by paired Student t test or ANOVA with Bonferroni post-test as appropriate using Origin2016 software. Differences were deemed significant if P was <0.05. Figure 1 shows representative APs and group analysis in HF and age-matched control myocytes before and after treatment with the selective I NaL inhibitor GS-967 (1 µmol/L). Baseline APD 95 was longer in HF versus control at 1 Hz pacing (269.5±17.5 versus 199.2±7.7 ms; P<0.001; Figure 1A and 1B). GS-967 decreased APD 95 in HF by 22% (to 211.6±6.8 ms; not significant) and also decreased APD 95 in control but by only 13% (to 174.2±5.9 ms; P<0.001). At faster pacing rates, APD 95 converged for HF and control and similarly for the +GS-967 treatment curves ( Figure 1B ). Resting membrane potential was slightly depolarized (by ≈4 mV; Figure 1C ) in HF consistent with reduced I K1 in HF. 4, 5, 14 AP amplitude was significantly lower (by 8-10 mV) in HF independent of GS-967 treatment. Similarly, the maximum rate of rise (dV/dt max ) during AP upstroke was also decreased by ≈25% in HF ( Figure 1D ). These effects are likely to be at least partly attributed to lower Na + channel availability (with the more positive diastolic V m ), but elevated intracellular [Na + ] ([Na + ] i ) and altered Na + channel expression (both known to occur in HF) [41] [42] [43] could also be involved. These effects were similar on acute I NaL inhibition with GS-967. The maximum repolarization rate (−dV/dt max ) during AP phase 3 was significantly slower in HF (by ≈25%), and I NaL block partially restored −dV/dt max and limited the difference between control and HF (≈15%). Collectively, these data are consistent with peak I Na amplitude in HF being normal except for slight reduction in availability associated with the slightly depolarized diastolic V m , and smaller AP amplitude and dV/dt max , but enhanced I NaL that contributes to APD prolongation and slowed repolarization. Figure 1E and 1F show that HF myocytes also exhibited higher STV at 1 and 2 Hz, in HF versus control (4.80±0.51 versus 3.21±0.21 ms, respectively; 1 Hz pacing; P<0.01). Importantly, GS-967 treatment in HF decreased not only mean APD 95 but also STV to control values (3.19±0.46 ms; not significant). GS-967 also decreased STV at all pacing rates in control (2.10±0.13 ms; P<0.001).
RESULTS

Frequency-Dependent Changes in AP Shape and Effect of I NaL Inhibition in HF
I NaL Magnitude and Dynamic Changes Under AP in HF
The AP data indicate increased depolarization drive during the AP plateau and repolarization phases in HF versus control myocytes. Thus, we studied the 3 major inward plateau currents (I NaL , I CaL , and I NCX ) under physiological AP clamp. We did not measure the fast Na + current because of technical limitations (peak I Na overlaps the capacitive transient under physiological AP clamp), but altered peak I Na can contribute to pathological excitability in HF. 44 The reduced dV/dt max observed ( Figure 1D ) would be consistent with reduced Na + current availability and peak I Na in HF. GS-967-sensitive I NaL and I Nife were recorded from the same myocyte using AP-clamp sequential dissection 21, 35 ( Figure I in the Data Supplement) with either preserved [Ca 2+ ] i cycling (Physiol) or with [Ca 2+ ] i buffered with 10 mmol/L BAPTA in the pipette (BAPTA i ).
Involvement of CaMKII was also tested using the selective CaMKII inhibitory peptide AIP. A previously recorded typical rabbit ventricular AP was used as voltage command in all AP-clamp experiments (ie, a canonical AP clamp analogous to the mean for 2 Hz where HF and control APD 95 were similar).
14 Because HF myocytes were larger (≈35% increase in cell capacitance), all reported currents are normalized to the corresponding cell capacitance.
I NaL was measured as GS-967-sensitive current under AP clamp (Figure 2 ; see reference 21 and Figure 1 therein for additional controls and technical details). 21 The density of I NaL increased during AP repolarization as the driving force for Na + influx increased, achieving peak density during phase 3 repolarization of the AP (at ≈−50 mV in both control and HF). Importantly, peak I NaL density was 82% higher in HF versus control myocytes in our physiological condition (−0.93±0.03 versus −0.51±0.01 A/F, respectively; P<0.001; Figure 2A and 2D). The I NaL I-V analysis reveals that I NaL is increased during the entire AP without change in V m dependence (Figure 2A, bottom) . Buffering [Ca 2+ ] i with BAPTA i did not alter peak I NaL density in control (−0.54±0.02 A/F; not significant; Figure 2E ) but decreased peak I NaL by 23% in HF (−0.72±0.03 A/F; P<0.001; Figure 2B ). Nevertheless, I NaL density and integral charge were still larger in HF versus control myocytes with BAPTA i (Figure 2E and 2F). AIP pretreatment (to inhibit CaMKII) decreased I NaL in HF to the level of untreated control (−0.54±0.02 A/F; not significant; Figure 2C and 2D). However, AIP also decreased I NaL in control (−0.37±0.01 A/F; P<0.001; Figure 2C and 2D), such that I NaL was still higher in HF versus control A, Representative APs recorded at 1 Hz steady-state pacing in HF and age-matched control before and after treatment with the selective late Na + current inhibitor GS-967 (GS; 1 µmol/L). B, Frequency dependence of AP duration measured at 95% of repolarization (APD 95 ). C, Resting membrane potential (RMP) was slightly more positive in HF in line with decreased AP amplitude (APA) at 1 Hz pacing. GS had no effect on either AP parameters. D, Maximal rate of rise (dV/dt max ) and maximal rate of phase 3 repolarization (−dV/dt max ) were significantly decreased in HF compared with control. GS increased −dV/dt max already in control but even more in HF. E, Representative Poincaré plots of 50 consecutive APD 95 values at 1 Hz pacing. F, Frequency-dependent short-term variability of APD 95 (STV). STV was increased at low pacing frequencies in HF, which was decreased with GS to the control level. Columns and bars represent mean±SEM. n refers to cells/animals measured in each group. Paired and unpaired Student t tests following ANOVA. *P<0.05, **P<0.01, ***P<0.001 vs control; †P<0.05, † †P<0.01 vs control+GS.
after AIP treatment (as for BAPTA i ). We conclude that I NaL is elevated in HF under all conditions studied, that basal I NaL at 2 Hz pacing with Ca 2+ transients is partly dependent on CaMKII activity, and that large I NaL increase in HF is substantially CaMKII dependent.
We used these data to update our most recent computational model of the rabbit ventricular myocyte. 36 The basal value of I NaL maximal conductance (G NaL ) was scaled to 0.0527 mS/µF to reflect the peak I NaL observed during the AP in control myocytes with physiological Ca 2+ handling. Inactivation of I NaL was set to 600 ms as previously. 45 G NaL was modeled as a function of chronic HF-induced remodeling (not influenced by acute CaMKII inhibition, ie, 50% increase in G NaL in failing versus nonfailing myocytes, guided by data in AIP-treated cells; Figure 2C ), and simu- I NaL was measured as GS-967 (1 µmol/L)-sensitive current in HF and age-matched control (Ctl). AP clamp using a prerecorded typical AP (shown above) was applied at 2 Hz pacing. A, I NaL traces (mean±SEM) recorded under preserved [Ca 2+ ] i cycling (physiol). I NaL was significantly increased already during the early plateau phase of the AP, and it achieved a nearly doubled peak density during phase 3 repolarization in HF cells having Ca 2+ transients. Current-voltage relationship under AP clamp is shown below. B, I NaL traces (mean±SEM) recorded under buffered [Ca 2+ ] i using 10 mmol/L BAPTA in the pipette (BAPTA i ). Buffering [Ca 2+ ] i significantly reduced I NaL peak density in HF. C, I NaL traces (mean±SEM) recorded in cells pretreated with the specific CaMKII inhibitor AIP (autocamtide-2-related inhibitory peptide; 1 µmol/L). AIP reduced I NaL in HF to the untreated Ctl level; however, AIP also decreased I NaL in Ctl. D, Peak I NaL density was significantly upregulated in HF under AP, partially by a CaMKII-dependent acute effect on I NaL . E, I NaL density measured at the mid-plateau of the AP. F, Net charges carried by I NaL under AP in HF and age-matched Ctl. Columns and bars represent mean±SEM. n refers to cells/animals measured in each group. ANOVA with Bonferroni post-test, *P<0.05, **P<0.01, ***P<0.001. G-I, Simulated time courses of I NaL under AP clamp in control and HF obtained with physiol, BAPTA i , and CaMKII inhibition conditions. lated CaMKII activation reproduced the increase in peak I NaL observed with physiological Ca 2+ handling versus CaMKII inhibition in both failing and nonfailing conditions, as done previously. 46 G NaL (in mS/µF) was calculated as where HF remodeling indicates the absence/presence of chronic HF-induced remodeling (0 and 1, respectively), and P NaVs (ranging from 0 to 1) is the fraction of phosphorylated Na + channels, modeled as described previously ( Figure IV in the Data Supplement). 46 The in silico AP-clamp experiments quantitatively reproduced the experimental data on the role of physiological Ca 2+ transients and CaMKII activity in upregulating I NaL in control and more strongly in HF ( Figure 2G through 2I).
Nifedipine-Sensitive Inward Current Changes in HF (I CaL and I NCX )
Next, we measured I Nife under AP clamp (Figure 3) . Under physiological conditions, nifedipine inhibits I CaL and consequently abolishes Ca 2+ transients. Note that I Nife was recorded when other Ca-sensitive currents (eg, I Ks , I K (Ca) , and I Cl (Ca) ) were pharmacologically inhibited (see Methods). Thus, the measured I Nife is a composite current containing I CaL and the inward shift in I NCX that is driven by elevated [Ca] i . Peak I Nife density in the early plateau phase of the AP (at ≈+35 mV in both control and HF) was unaltered in HF versus control under physiological condition ( Figure 3A and 3D) . However, I Nife was slightly increased in HF during the AP plateau and terminal repolarization phases ( Figure 3A and 3E nel subunit composition, or alternatively, but less likely, 41 to more inward I NCX . In contrast, when I Nife was recorded with BAPTA i (ie, without Ca 2+ transient and inward I NCX ), peak I Nife density (more exclusively I CaL ) under AP clamp was significantly decreased in HF ( Figure 3B and 3D ), but BAPTA also abolished the small hump near terminal repolarization, consistent with loss of expected inward I NCX at this time (note superimposition of I Nife versus V m curve between −80 and −40 mV). In BAPTA i , the I Nife decay was still slower in HF versus control, despite low CDI expected in both cases ( Figure 3B and 3E) . When CaMKII was inhibited, the I Nife density and integrated charge movement were reduced versus Physiol for both HF and control ( Figure 3C, 3D, and 3F ). Because the peak inward I Nife is likely dominated by peak I CaL , this might reflect the involvement of basal CaMKII activity in maintaining physiological peak I CaL when Ca 2+ transients and CaMKII are functional ( Figure 3A and 3D) .
Changes in the Biophysical Properties of I CaL in HF
Next, we measured the biophysical parameters of I CaL using conventional square-pulse voltage clamp and [Ca 2+ ] i buffered to 100 nmol/L by inclusion of 5 mmol/L EGTA in the pipette solution. The peak density of I CaL and the I-V relationship were not significantly different ( Figure 4A ), but the steady-state activation curve of I CaL was shifted slightly (4.7 mV) to more negative potentials in HF versus control ( Figure 4B ). The inactivation time constants of I CaL (obtained by biexponential fits of I CaL decay) were slightly prolonged in HF versus control, consistent with slower CDI in HF ( Figure 4D and 4E), but V m dependence of inactivation ( Figure 4C ) and the recovery from inactivation kinetics ( Figure 4F ) were unchanged.
We also analyzed I CaL in the pipette conditions used for AP-clamp studies (Physiol, BAPTA i , and CaMKII inhi- ] i =100 nmol/L) in the pipette. B, Steady-state activation of I CaL was shifted by 5 mV to more negative potentials in HF. C, Steady-state inactivation of I CaL was unaltered in HF. D, Representative I CaL traces elicited by depolarization pulses to 0 mV (voltage protocol shown in the inset). E, Decay time constants (τ fast and τ slow ) of I CaL were slightly increased in HF. F, I CaL recovery from inactivation was unchanged in HF. G, Representative I CaL traces under preserved [Ca 2+ ] i cycling (physiol). I CaL was elicited with depolarization pulse to 0 mV at 2 Hz. Inset shows significantly increased decay time constants but unaltered I CaL amplitude in HF. H, Representative I CaL traces under buffered [Ca 2+ ] i using 10 mmol/L BAPTA in the pipette (BAPTA i ). Inset shows that the amplitude of the fast I CaL decay was significantly reduced in HF vs control, whereas τ fast was still slightly increased in HF. I, Representative I CaL traces following specific CaMKII (Ca 2+ /calmodulin-dependent protein kinase II) inhibition with AIP (autocamtide-2-related inhibitory peptide; 1 µmol/L). Inset shows the decay time constants of I CaL and the corresponding amplitudes. The inactivation time course of I CaL was fitted by a biexponential function. Columns and bars represent mean±SEM. n refers to cells/animals measured in each group. ANOVA with Bonferroni post-test, *P<0.05, **P<0.01, ***P<0.001. bition). Peak I CaL density elicited by a step pulse to 0 mV was unaltered in HF versus control with preserved [Ca 2+ ] i cycling ( Figure 4G ). This contrasts with the diminished peak I CaL observed when either [Ca 2+ ] i is clamped low (BAPTA i ) or CaMKII is inhibited ( Figure 4H and 4I) , both conditions where CaMKII-dependent CDF is suppressed. We infer that Ca 2+ -dependent CaMKII upregulates peak I CaL (via CDF) in HF to the level of control cells (when measured in physiological conditions; compare Figure 4G through 4I) .
CDI of I CaL was, as expected, stronger under physiological [Ca 2+ ] i versus when [Ca 2+ ] i was buffered by EGTA or BAPTA ( Figure 4G versus Figure 4E and 4H) . However, the τ of inactivation was significantly slowed in HF versus control ( Figure 4G , inset), consistent with known smaller Ca 2+ transients in HF and thus less CDI. 4, 9 Using 10 mmol/L BAPTA in the pipette (BAP-TA i ) should eliminate both CDI and CDF ( Figure 4H) . Indeed, BAPTA i significantly slowed the τ of inactivation (versus Physiol or EGTA; Figure 4H and 4I) but τ fast was still slightly slower in HF versus control (Figure 4H, inset) . When CaMKII was inhibited with AIP ( Figure 4I ), the inactivation τ values were more like those in physiological buffer ( Figure 4G ). The slowed I CaL inactivation in HF was still observable in BAPTA, consistent with part of that effect being independent of CDI, and may reflect some PKA-dependent effect in HF myocytes.
47,48
Computer Models Help to Report Physiological I CaL and I NCX During the AP in HF
To help delineate the relative contributions of I CaL and I NCX to I Nife under AP clamp, we used our rabbit ventricular myocyte model 36 with I CaL properties tuned to those measured in Figure 4 (for details, see Methods, Table I Figure 5A and 5B shows calculated I CaL and I Na/Ca in physiological conditions, which have the expected overall shapes. 10, 37, 41, 49, 50 After I CaL activation and the start of SR Ca 2+ release, CDI causes I CaL decline to a plateau that can increase slightly as AP repolarization causes an increase in the Ca 2+ driving force, until terminal repolarization deactivates I CaL . I NCX is initially outward (Ca 2+ influx) driven by the rapid AP depolarization. But once SR Ca 2+ release occurs, the high submembrane [Ca 2+ ] i drives a first peak of inward I NCX , which declines as [Ca 2+ ] i falls but is followed by a second peak during terminal repolarization (driven by voltage) until the [Ca 2+ ] i reaches the diastolic level. In HF, the I CaL waveform is similar, although CDI is slowed. (Ca 2+ influx) throughout much of the AP, and then that same amount of Ca 2+ that entered via outward I NCX is extruded via inward I NCX during repolarization. Higher NCX expression in HF myocytes makes inward and outward I NCX larger in HF. The residual I NCX during nifedipine exposure must be taken into account when inferring the predicted I Nife shown in Figure 5E and 5F. The shape of the predicted I Nife is similar to the I Nife recorded in vitro under AP clamp in cardiomyocytes ( Figure 3A ). This analysis also explains why the inward I NCX tail at terminal repolarization is less prominent than expected in the measured I Nife traces in Figure 3A and 3C. Although this simulation analysis cannot extract absolute I CaL and I NCX waveforms that occur during the AP in control versus HF myocytes, Figure 5A provides a qualitative estimate of likely changes that occur in I CaL and I NCX during the HF AP.
Altered β-Adrenergic Response of Inward Currents in HF
Elevated sympathetic tone is often reported in HF in conjunction with altered responses to βAR activation. We, therefore, tested the effects of acute βAR stimulation on I NaL and I Nife in HF versus control myocytes using AP clamp. Because downstream effects of βAR stimulation are mediated both by PKA and CaMKII and the activities of these kinases are known to be altered in HF, ionic currents were measured again with physiological preserved [Ca 2+ ] i cycling and with heavily buffered [Ca 2+ ] i . Figure 6A shows I NaL measured after βAR agonist ISO (10 nmol/L) treatment. ISO increased I NaL in both control and HF myocytes but by a much larger percentage in control (by 110% versus 40%; Figure 6C) . Nevertheless, the resulting I NaL with ISO (and its integral) was still larger in HF. Buffering [Ca 2+ ] i reduced the effect of ISO on I NaL , indicating the involvement of Ca 2+ and CaMKII (as well as PKA) in mediating the ISO effect. Again, the effect on control was larger than in HF (70% versus 30%). Moreover, in BAPTA i , the ISO-induced I NaL peak density was not significantly different between control and HF. That is consistent with Ca 2+ or CaMKII dependence being The late Na + current (I NaL ) and the nifedipine-sensitive current (I Nife ) were recorded after 2-min pretreatment with βAR agonist isoproterenol (ISO; 10 nmol/L). A, I NaL traces (mean±SEM) under action potential (AP) clamp at 2 Hz pacing measured with preserved [Ca 2+ ] i cycling (physiol) and [Ca 2+ ] i buffering using 10 mmol/L BAPTA in the pipette (BAPTA i ) after ISO pretreatment in HF and age-matched control (Ctl). Current-voltage relationship under AP clamp is shown below. B, I Nife traces (mean±SEM) under AP clamp after ISO pretreatment in HF and age-matched Ctl. C, Upregulation of I NaL peak and net charge induced by ISO, which was reduced with BAPTA i . D, Robust increase in I Nife after ISO stimulation, which was reduced in BAPTA i , indicating a Ca 2+ -dependent pathway in mediating the response of βAR stimulation on I Nife (besides the classical protein kinase A effect). HF cells exhibited significantly reduced response of I Nife after ISO stimulation both with and without [Ca 2+ ] i buffering. Symbols and bars represent mean±SEM. n refers to cells measured in each group, and the cells in each group came from 3 to 6 individual animals. ANOVA with Bonferroni post-test, *P<0.05, **P<0.01, ***P<0.001.
involved with ISO-induced higher I NaL in HF versus control.
I Nife also increased after ISO treatment, as expected for the known effects of βAR stimulation on I CaL and Ca 2+ transient amplitude (which drives inward I NCX ; Figure 6B) . Again, the ISO-induced increase in I Nife was smaller in HF. This blunted βAR response in HF was present with both physiological Ca 2+ cycling and BAP-TA i conditions, but for I Nife , the ISO-induced increase for BAPTA i (2.4-fold in control versus 2-fold in HF) was only slightly smaller than for physiological conditions (3.3-fold in control versus 2.2-fold increase in HF; Figure 6D ).
Because the ISO effects on both I NaL and I Nife were blunted in HF versus control, we tested whether this was because of decreased ISO sensitivity or limited maximal response. ISO concentrations between 3 and 300 nmol/L were applied in HF and control (Figure 7) . Steady-state contracting AP-clamped myocytes in HF were unstable at higher ISO concentrations; so these experiments were performed with 10 mmol/L BAPTA in the pipette (BAPTA i ). ISO increased I NaL in both control and HF, but the half maximal effective concentration [ISO] was slightly higher in HF (16.1±1.4 versus 10.5±1.3 nmol/L; P<0.05; Figure 7A ). However, the maximal ISO-induced I NaL density was not different in control versus HF ( Figure 7A ). I CaL was also markedly increased after ISO application with similar half maximal effective concentration (≈12 nmol/L) in control and HF. However, the maximal I CaL response after ISO stimulation was only half as much in HF versus control (4.6-versus 2.7-fold increase in peak I CaL ; Figure 7B ). This indicates unchanged ISO sensitivity but weaker potency in raising I CaL . The blunted ISO response of I CaL in HF may limit Ca 2+ transients and inotropy in HF during sympathetic activity.
Relative Contributions of Inward Currents to AP Plateau and Phase 3 Repolarization
The dynamic interplay of time-and voltage-dependent activation and inactivation of inward currents governs the AP waveform. Each inward current has a unique profile and magnitude during the cardiac AP. The relative contributions of major inward currents (I NaL , I Nife ≈I CaL +I NCX ) during the AP plateau and repolarization in control and in HF are shown in Figure 8 , compared at different V m (+40, −20, and −60 mV), and shown as integrated charge movement during the AP (Figure 8,  insets) . I Nife early in the AP (phase 1, at +40 mV) predominantly represents I CaL , whereas late during terminal repolarization (at −60 mV) is mainly inward I NCX (during physiological Ca 2+ transients). Total inward current during AP phase 1 (early repolarization) was unaltered in HF versus control in physiological conditions but had greater I NaL contribution in HF ( Figure 8A and 8B). Later during AP repolarization (−20 and −60 mV), total inward current was higher in HF, mainly because of increased I NaL ( Figure 8B ). In control myocytes, ISO increased both inward currents, but the smaller ISO-induced increases of I CaL in HF reduced I CaL throughout the AP ( Figure 8C ). Total inward current in HF was reduced early (+40 mV) but increased progressively later in the AP (−20 and −60 mV), which could promote failure of repolarization and EADs. Despite βAR hyporesponsiveness, I NaL and I NCX were still higher in HF and contributed to that increased total inward current late in the AP (with ISO).
In contrast to physiological conditions, CaMKII inhibition limited both I NaL and I Nife increases in HF and abolished differences in late AP total inward current Figure 7 . βAR (β-adrenergic receptor) responsiveness of inward currents in heart failure (HF). Dose-response effect of isoproterenol (ISO) on late Na + current (I NaL ) and L-type Ca 2+ current (I CaL ) peak densities under action potential clamp at 2 Hz pacing rate. Pipette solution contained 10 mmol/L BAPTA (BAPTA i ). A, I NaL measured as GS-967-sensitive current significantly increased after ISO application. I NaL sensitivity (half maximal effective concentration [EC 50 ]) to ISO was slightly reduced in HF, and I NaL exhibited similar maximal response in HF than in control, despite the increased basal I NaL in HF. B, I CaL measured as nifedipine-sensitive current was markedly increased after ISO treatment; however, the magnitude of the response was significantly blunted in HF with no change in ISO sensitivity. EC 50 between HF and control ( Figure 8D versus Figure 8B) . Similarly, using strong [Ca 2+ ] i buffering also reduced I NaL and I Nife in HF, and total inward current was unaltered early but still slightly increased late during the AP in HF versus control ( Figure 8E ). ISO did not change total inward current during phase 3 of the AP in the presence of BAPTA i (presumably because inward I NCX is prevented; Figure 8F ).
DISCUSSION
Arrhythmogenic AP Alterations in HF and the Role of Increased I NaL HF-induced ionic remodeling causes characteristic changes in ventricular AP profile in our rabbit HF model, including APD prolongation, reduction of phase 1 and phase 3 repolarization rates, depolarized resting membrane potential, and reduced AP upstroke velocity under steady-state pacing ( Figure 1A through 1D) , which mostly agree with literature data on various animal HF models and human HF. [4] [5] [6] [7] 18, 25, 26, 51 Moreover, temporal variability of AP repolarization (characterized by STV) was also increased in HF ( Figure 1E and 1F) , further enhancing the arrhythmogenic substrate. [6] [7] [8] Delayed afterdepolarizations are frequently reported in HF, 3, 4 and we have shown previously increased delayed afterdepolarizations that depended on CaMKII-mediated SR Ca 2+ leak after cessation of pacing bouts in this HF model. 14, 52, 53 The HF-related arrhythmogenic alterations in ventricular AP were more pronounced at slow pacing rates than at fast pacing rates (Figure 1 ) in line with previous experimental 14, 54 and clinical data. 55 Importantly, selective I NaL inhibition in HF reduced both APD and STV to control values at all pacing rates. The rate dependence of APD prolongation and increase in STV associated with enhanced I NaL in HF can be explained by the following mechanisms: (1) I NaL availability may decrease at faster pacing rates 56 ; (2) ] i cycling is preserved, upregulation of I NaL increased the net inward current during phase 3 of AP. C, βAR stimulation using isoproterenol (ISO; 10 nmol/L) significantly upregulated not only I CaL but also I NaL and I NCX . However, HF cells were hyporesponsive to ISO-induced stimulation (ie, both I CaL and I NaL increased in a smaller extent than in control); thus net inward current at +40 mV (predominantly I CaL ) was significantly decreased in HF compared with control. Despite hyporesponsiveness, the net inward current during AP terminal repolarization was still significantly increased in HF because of the upregulated I NaL and I NCX . D, CaMKII (Ca 2+ /calmodulin-dependent protein kinase II) inhibition using the specific inhibitory peptide AIP (autocamtide-2-related inhibitory peptide) largely diminished the difference between control and HF by reducing the upregulated I NaL in HF. E, Buffering [Ca 2+ ] i (BAPTA i ) eliminated the inward I NCX and significantly decreased the extent of I NaL enhancement in HF limiting the increase in net inward current. F, Under βAR stimulation in BAPTA i , HF cells exhibited slightly decreased I CaL but similar I NaL density compared with control. The contributions of these inward currents to total net charge are shown in insets. Columns and bars represent mean±SEM. Statistics and n numbers are shown in Figures 2 through 6. K + currents that counterbalance I NaL during AP plateau and phase 3 are also increased in HF under physiological conditions at faster pacing rates, 14 and the increase of those K + currents has also been shown to be Ca 2+ / CaMKII dependent. 14 In line with our results in HF rabbits, it has been shown that both the I NaL inhibitor ranolazine and AIP exert potent antiarrhythmic effects in a transverse aortic constriction (pressure overload)-induced HF model in mice, 18 as well as in failing human myocytes. 24 Inhibition of the enhanced I NaL prevented APD prolongation and STV enhancement in our rabbit HF model; thus, it reduced the substrate for arrhythmias. Moreover, enhanced I NaL can also contribute to increased Na + loading and (via NCX) Ca 2+ loading and contribute to increased occurrence of afterdepolarizations that triggers arrhythmias in HF. 23 Furthermore, enhanced Na + current and spontaneous SR Ca 2+ leak can contribute to increased STV. 33, 58 Of note, the I NaL maximal conductance used in the mathematical model to fit our AP-clamp current data is ≈10-fold larger than previously estimated in rabbit myocyte experiments using a different experimental approach (1-day cell culture, square voltage pulses to −20 mV, abolished Ca 2+ cycling). 45 Physiologically dynamic Ca 2+ -dependent CaMKII activation and AP shape may contribute to these differences, which underlines the importance of using physiological AP clamp to measure ionic currents.
Changes in Inward Currents in HF That
Shape the AP Electrophysiological remodeling in HF leads to arrhythmogenic alterations in AP morphology that involves changes in the expression and regulation of multiple ion channels. 26 Experimental data detailing such changes have been integrated in computational models to understand mechanistically how arrhythmogenesis occurs in HF. 40, 59 However, ionic currents were usually recorded under nonphysiologic conditions, which may mask modulation by Ca 2+ transients and CaMKII on ionic currents. This regulation may be even more impactful under pathological states, including HF (where CaM-KII activity is increased). 14 /CaM binding to the IQ motif of these channels is known to enhance CDI that is evident, especially for I CaL , 61,62 but a similar mechanism has been shown for fast I Na and I NaL . 63, 64 CDI serves as a feedback mechanism preventing cellular Ca 2+ overload. 29 In contrast, CaMKII increases both I CaL (via CDF) [27] [28] [29] and I NaL . 17, 64 I NaL represents a noninactivating or slowly inactivating component of Na + current that persists throughout the AP plateau and phase 3, as shown in Figure 2 . The gating mechanisms contributing to I NaL have been extensively studied and may include the early burst and late scattered openings, nonequilibrium gating, and steady-state window current (overlap between the activation and inactivation curves); however, the details are still not fully resolved. 65 I NaL enhancement in HF has been demonstrated in different animal models and human 11, 12 ; however, we found an even more pronounced increase in I NaL under physiological AP clamp than previous reports of smaller I NaL under nonphysiological voltage-clamp conditions. 11, 17, 19, 45, 56 We showed that I NaL upregulation in HF was largely Ca 2+ dependent (Figure 2 ), in line with the increased CaMKII activity in HF that upregulates I NaL . [17] [18] [19] However, I NaL was still increased in HF following cytosolic Ca 2+ buffering with BAPTA, potentially reflecting an increased basal PKAdependent phosphorylation of Na + channels or remodeling with increased expression of neural Na + channel isoforms in HF. 42, 43 I CaL is the main inward current during the AP plateau in ventricular cardiomyocytes, as shown in Figure 3 . I CaL amplitude was unchanged in HF under physiological conditions or using the slow Ca 2+ buffer EGTA (which does not eliminate subsarcolemmal [Ca 2+ ] changes; Figure 4 ). In contrast, I CaL was slightly decreased in HF when measured with BAPTA i and AIP, indicating a key role of CaMKII in maintaining I CaL in HF. I CaL decay was significantly slower in HF. This might be explained by reduced CDI (because of reduced Ca 2+ transient amplitude), enhanced CDF (via increased CaMKII activity), or altered Ca 2+ channel subunit composition. Increased expression of auxiliary β 2 subunit is known to occur in HF, 66 and it has been shown to reduce the rate of I CaL inactivation, shift activation to more negative potentials, and significantly diminishes PKA response, all in agreement with our data. [67] [68] [69] The difference in nifedipine-sensitive inward current measured with and without [Ca 2+ ] i buffering suggests enhanced I NCX , in agreement with previous reports. 9 I NCX kinetics during the rabbit ventricular AP during Ca 2+ transients was previously measured in an elegant study of Weber et al. 49 Here, we could not explicitly separate I NCX from I Nife (Figure 3 ), but our measurements of I CaL alone ( Figure 4 ) and in silico models ( Figure 5) were consistent with the upregulation of NCX previously reported in this HF model. Our modeling provided quantitative estimates of I NCX dynamics under AP clamp in control and HF ( Figure 5) . Importantly, the increased I NCX peak during phase 3 of AP repolarization in HF may contribute to early afterdepolarizations and APD prolongation. However, the precise contribution of I NCX to arrhythmogenic AP alterations in HF requires further studies.
β-Adrenergic Stimulation-Induced Changes in Inward Currents in HF
Increased sympathetic activity but blunted β-adrenergic response are hallmarks of HF and significantly contribute to contractile dysfunction, alterations in Ca 2+ handling system, and arrhythmogenesis. 4, 14, 52, 70, 71 I CaL , I NaL , and I NCX are all known to be increased in ventricular myocytes after βAR stimulation. Downstream signaling mediating βAR effects on Na + and Ca 2+ channels involves both PKA and CaMKII; however, there is still debate on the exact molecular mechanisms and phosphorylation sites. 72, 73 We found that I CaL peak was upregulated mainly by PKA during ISO stimulation (by comparing physiological and BAPTA i conditions), whereas I NaL was upregulated by PKA and CaMKII in an almost equal manner both in control and HF ( Figure 6) . Importantly, the ISO-induced increases in I CaL and I NaL were limited in HF both in physiological and BAPTA i conditions ( Figure 6 ). While the ISO half maximal effective concentration for I NaL activation was slightly increased in HF, the eventual maximal I NaL density was the same in HF versus age-matched control, in part, because of the increased basal I NaL in HF ( Figure 7A ). On the contrary, the ISO half maximal effective concentration for I CaL activation was not altered in HF, but the maximal effect was ≈40% smaller in HF versus age-matched control ( Figure 7B ) similar to prior report in this HF model. 4 This blunted βAR response could be because of reduced number of β 1 ARs, 70 lower local cAMP levels, 71 or altered phosphatases and phosphosdiesterases in HF. 52 I CaL, I NaL , and I NCX reach their peak density sequentially during the AP, and their relative contributions to net inward current also dynamically change during the AP time course, as demonstrated previously in pig 51 and guinea pig 20, 31 cardiomyocytes. In this study, we demonstrated their detailed contribution in a chronic pressure/ volume overload-induced HF rabbit model (Figure 8 ). The enhanced I NaL and I NCX increase the demand on the repolarizing K + currents, which are also remodeled in HF. 13, 14 The balance between these depolarizing and repolarizing currents in HF is shifted during phase 3 of the AP so as to slow repolarization and prolong APD.
51
Conclusions
We measured I NaL under physiological recording conditions (AP clamp with physiological ionic composition, pacing rate, [Ca 2+ ] i , and temperature) and demonstrated a key role I NaL enhancement in HF in APD prolongation and increased STV, especially at slow heart rates. I NaL increase and its consequences may be exacerbated on sympathetic activation. Our results agree with previous studies showing beneficial effects of I NaL inhibition in HF and point to I NaL as a therapeutic target to reduce the risk of arrhythmias in HF. 18, 24 However, it should be considered that selective I NaL inhibition decreased APD, albeit more modestly, in control. On the contrary, hyporesponsiveness of I CaL to βAR stimulation limits Ca 2+ entry, and that can aggravate the contractile deficit in HF. Our data demonstrate the importance of utilizing physiological recording conditions when measuring ionic currents, especially in cardiac pathologies associated with altered [Ca 2+ ] i handing and CaMKII activity, to improve our understanding of electrophysiological remodeling and mechanistic bases of arrhythmogenesis in HF.
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